Provided by Tiger Fintech (Singapore) Pte. Ltd.

MediWound

18.72
+0.17000.92%
Volume:367.00
Turnover:6.81K
Market Cap:240.02M
PE:-7.12
High:18.72
Open:18.53
Low:18.53
Close:18.55
52wk High:22.51
52wk Low:14.14
Shares:12.82M
Float Shares:9.17M
Volume Ratio:0.29
T/O Rate:0.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.6289
EPS(LYR):-3.0346
ROE:-148.65%
ROA:-22.25%
PB:11.93
PE(LYR):-6.17

Loading ...

MediWound’s EscharEx Study: A Potential Game-Changer for Venous Leg Ulcers

TIPRANKS
·
Oct 28

Craig-Hallum Reaffirms Their Buy Rating on Mediwound (MDWD)

TIPRANKS
·
Sep 30

MediWound Prices $30 Million Registered Direct Offering

MT Newswires Live
·
Sep 29

MediWound Announces $30 Million Direct Offering to Boost Operations

TIPRANKS
·
Sep 29

BUZZ-MediWound slides after $30 mln direct stock offering announced

Reuters
·
Sep 29

Mediwound Announces $30 Million Registered Direct Offering of Ordinary Shares

THOMSON REUTERS
·
Sep 29

MediWound Ltd. Announces $30 Million Registered Direct Offering of Ordinary Shares Led by U.S. Mutual Fund

Reuters
·
Sep 29

Mediwound (MDWD) Gets a Buy from Craig-Hallum

TIPRANKS
·
Sep 25

Mediwound Ltd - Announces Tga Approval for Nexobrid in Australia

THOMSON REUTERS
·
Sep 25

Mediwound Ltd - Manufacturing Expansion to Complete by Year-End 2025

THOMSON REUTERS
·
Sep 25

MediWound Expands Global Reach with Marketing Approval of NexoBrid® in Australia

GlobeNewswire
·
Sep 25

MediWound Ltd.'s NexoBrid® to be Featured in 36 Presentations at European Burns Association Congress

Reuters
·
Sep 02

MediWound to Present at the H.C. Wainwright 27th Annual Global Investment Conference

GlobeNewswire
·
Aug 20

MediWound Q2 2025 Earnings Call Summary and Q&A Highlights: Clinical Progress and Manufacturing Expansion Drive Strategic Milestones

Earnings Call
·
Aug 14

MediWound Ltd. Unveils Presentation on Next-Generation Enzymatic Therapeutics for Tissue Repair

Reuters
·
Aug 14

MediWound Q2 revenue up 43%, beats estimates

Reuters
·
Aug 14

MediWound Q2 EPS $(1.23) Misses $(0.57) Estimate, Sales $5.708M Beat $5.677M Estimate

Benzinga
·
Aug 14

MediWound Ltd. Reports Increased Adjusted EBITDA Loss of $8.5 Million for H1 2025, Up from $6.2 Million in 2024

Reuters
·
Aug 14

Mediwound Ltd: Nexobrid® Manufacturing Expansion on Track; Full Operational Capacity Expected by 2025 End

THOMSON REUTERS
·
Aug 14

Mediwound Q2 Revenue USD 5.7 Million VS. Ibes Estimate USD 5.68 Million

THOMSON REUTERS
·
Aug 14